Trademarkia Logo

Canada

C$
FABLE THERAPEUTICS
FORMALIZED

on 1 May 2025

Last Applicant/ Owned by

Fable Therapeutics, Inc.

One Kendall Square, B200Suite 001Cambridge, MA 02139

US

Serial Number

2396287 filed on 1st May 2025

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

FABLE THERAPEUTICS

Trademark usage description

research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery serv Read More

Classification Information


Class [042]
Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; pharmaceutical research and development services; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; providing an online non-downloadable computer software platform for discovering proteins or drugs, forecasting potential uses of proteins or drug compounds and generating insights from screening and analyzing molecules, featuring software using artificial intelligence and machine learning; providing temporary use of non-downloadable computer software for discovering proteins or drugs, forecasting potential uses of proteins or drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; software as a service (SAAS) services featuring software for discovering proteins or drugs, forecasting potential uses of proteins or drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; providing an online non-downloadable computer software platform for analyzing molecular data; providing temporary use of non-downloadable computer software for generating or analyzing molecular data for biotechnology and pharmaceutical companies; software as a service (SAAS) services featuring software for generating or analyzing molecular data for biotechnology and pharmaceutical companies; preclinical drug discovery and development services used for identifying, designing, and optimizing chemical or biological compounds; pharmaceutical evaluation and preclinical evaluation of biological or chemical series and biological or chemical compounds in drug discovery; pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing biological or chemical series and biological or chemical compounds via software using artificial intelligence and machine learning; providing an online searchable database in the fields of proteins or pharmaceuticals for scientific research purposes, in particular, pharmaceutical research and development, scientific research and development of proteins or pharmaceutical preparations, scientific development of new uses for proteins or pharmaceutical compounds, and scientific technical research; scientific research and development for forecasting the use of molecules as diagnostics, prognostics, or drug compounds and developing new uses for pharmaceutical compounds; research and development in the field of drug discovery and development, diagnostics or prognostics; drug discovery services, namely, discovering novel molecules to develop into drug compounds; medical research and development in the field of biopharmaceuticals, diagnostics, prognostics, or protein engineering; providing temporary use of non-downloadable software for the analysis of proteins; scientific research in the field of production and analysis of proteins; scientific services in the field of development of proteins for use as pharmaceuticals.


Classification kind code

12

Mark Details


Serial Number

2396287

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 30
on 1st May 2025
Filed
Submitted for opposition 1
on 1st May 2025
Created
Submitted for opposition 31
on 1st May 2025
Formalized